Sep 12 |
Update: Moderna Shares Fall After Cutting Annual R&D Spending by $1.1 Billion From 2027
|
Sep 12 |
Dow Jones Eases But Nasdaq, S&P Climb; Nvidia Moves Past Important Level On Analyst Views (Live Coverage)
|
Sep 12 |
Moderna to Cut Research, Development Spending, Prioritize New Product Approvals
|
Sep 12 |
Moderna Stock Heads to Its Lowest Since 2020. What Is Spooking the Market.
|
Sep 12 |
Moderna: Fresh Sell-Off On Cost Cutting Initiatives, Short-Term Outlook Troubling
|
Sep 12 |
Biggest stock movers today: WBD, MPW, MRNA, SIG, and more
|
Sep 12 |
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations
|
Sep 12 |
Moderna Shares Slide as Vaccine Maker Cuts R&D Spending Plans
|
Sep 12 |
Moderna stock plunges after slashing R&D budget
|
Sep 12 |
Moderna Plunges as Sales View Disappoints, Research Budget Cut
|